HAEE ammonium salts — RU2784249C1
Sergey A. Kozin · 2022 · RU2784249C1 · patent family RU2784249C1
Published 2022-11-23.
Reported patent results
Reported findings
The disclosure reports preserved active content for the ammonium salts within assay precision. Unformulated HAEE fell to 67.4%.
HPLC measurement of active content after accelerated storage for six months at 40 °C and 75% relative humidity. Reported analytical error was 1%.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Six-month accelerated storage | The disclosure reports preserved active content for the ammonium salts within assay precision. Unformulated HAEE fell to 67.4%. |
These are accelerated storage and chemical characterization results for a specified HAEE preparation. Clinical effects and HAEEPGP stability were outside the experiment.
Source for these results ↗ · Reviewed 2026-11-12
Patent claims and provenance
Formulation. Claims mono- and disubstituted ammonium salts of HAEE and their preparations.
These are accelerated storage and chemical characterization results for a specified HAEE preparation. Clinical effects and HAEEPGP stability were outside the experiment.
- Publication
- RU2784249C1 ↗ · 2022-11-23
- Earliest priority / filing
- 2022-07-15 / 2022-07-15
- Original applicant / assignee
- Lifemission LLC
- Indexed status
- Not shown; official status unverified · checked 2026-11-12
- Patent family
- Grouping identifier unavailable · family publications are related filings, not independent studies.
Original title, inventors and related publications
HAEE ammonium salts
Inventors: Sergey A. Kozin.
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- These are accelerated storage and chemical characterization results for a specified HAEE preparation. Clinical effects and HAEEPGP stability were outside the experiment.
- These are accelerated storage and chemical characterization results for a specified HAEE preparation. Clinical effects and HAEEPGP stability were outside the experiment.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Available format: Original patent text and indexed metadata
Material reviewed: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related publications may cover the same research program or participants.
Source access
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Source reviewed 2026-11-12.
Source type: Patent publication
Citation and original source
Original source: Sergey A. Kozin. HAEE ammonium salts — RU2784249C1 RU2784249C1 · patent family RU2784249C1 2022.
Molekul research summary: https://molekul.io/research/patent-ru2784249c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry